Sensyne Health signs collaboration agreement with Bayer
OXFORD, UK: Sensyne Health plc, the British clinical AI technology company, has signed an initial two-year collaboration agreement with Bayer to accelerate the clinical development of new treatments for cardiovascular disease using Sensyne Health’s proprietary clinical AI technology platform. The initial agreement will generate revenues for Sensyne Health of £5 million across the two-year collaboration….